• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Glad we aren’t them. ( look down )





PharMEDium rejects (defined as anybody that was still "working" there) were not shocked by this news. They will continue to suckle the company teet with a six month paid for severance. The company has been on a downward trend ever since being purchased by ABC.